AQR Capital Management
SPRY icon

AQR Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

AQR Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
+25,877
New +$248K ﹤0.01% 3589
2025
Q3 		– Sell
-16,132
Closed -$282K – 3579
2025
Q2 		$282K Buy
16,132
+5,016
+45% +$72.4K ﹤0.01% 2899
2025
Q1 		$140K Buy
+11,116
New +$134K ﹤0.01% 2953
2022
Q3 		– Sell
-19,845
Closed -$84K – 2311
2022
Q2 		$84K Buy
19,845
+8,896
+81% +$31K ﹤0.01% 2106
2022
Q1 		$38K Buy
+10,949
New +$47.7K ﹤0.01% 2191

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return